← Leaderboards
Tony Yuen
Icahn School Of Medicine At Mount Sinai
$10,254,831
Attributed
$24,700,400
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.8M · FY2021–25$10M$7.5M$5M$2.5M$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$24,700,400 · 6
By mechanism
R01$12,892,767 · 3
U01$8,293,749 · 1
R61$2,129,396 · 1
U19$1,384,488 · 1
Top collaborators
- Mone Zaidi22 shared
- Se-Min Kim6 shared
- Yelena Ginzburg5 shared
- Vahram Haroutunian5 shared
- Ki Ann Goosens1 shared
- Vitaly Anatolievich Ryu1 shared
- Weibin Zhou1 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Mone Zaidi$25,912,145
- Giovanni Manfredi$21,254,007
- Doris A Germain$10,430,941
- Carol Prives$28,176,184
- Balaji Manicassamy$10,074,679
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposOsteoporosisBoneBone LossPreventBrainWomanCellsMouse ModelHormonesBone MassOvariectomyAgedMaleKnock-DownFemalePathway InteractionsAgingEvaluationAffectImpaired CognitionLoss Of FunctionBone CellPhenotype
Grant awards (24)
AAV-mediated Interrogation of the Brain FSH Receptor$2,129,396
R61 · FY2025 · AG · contact PI
A Humanized Monoclonal FSH Blocking Antibody for Alzheimer's Disease$1,616,919
U01 · FY2025 · AG
Elevated FSH - A Driver for Sex Differences in Alzheimer's Disease$1,242,150
R01 · FY2025 · AG
Proof-of-Concept and Mechanistic Studies to Repurpose Erectile Dysfunction Drugs for Elderly Females$678,675
R01 · FY2025 · AG · contact PI
Deconvoluting the Mechanism of FSH Action on Bone and Body Fat With Aging$580,384
U19 · FY2025 · AG · contact PI
The Role of Erythroferrone in Regulating Bone Metabolism in Beta-Thalassemia$570,650
R01 · FY2025 · DK
A Humanized Monoclonal FSH Blocking Antibody for Alzheimer's Disease$1,652,369
U01 · FY2024 · AG
Elevated FSH - A Driver for Sex Differences in Alzheimer's Disease$1,267,500
R01 · FY2024 · AG
Deconvoluting the Mechanism of FSH Action on Bone and Body Fat With Aging$804,104
U19 · FY2024 · AG · contact PI
Proof-of-Concept and Mechanistic Studies to Repurpose Erectile Dysfunction Drugs for Elderly Females$692,527
R01 · FY2024 · AG · contact PI
The Role of Erythroferrone in Regulating Bone Metabolism in Beta-Thalassemia$543,541
R01 · FY2024 · DK
A Humanized Monoclonal FSH Blocking Antibody for Alzheimer's Disease$1,654,767
U01 · FY2023 · AG
Elevated FSH - A Driver for Sex Differences in Alzheimer's Disease$1,267,500
R01 · FY2023 · AG
Proof-of-Concept and Mechanistic Studies to Repurpose Erectile Dysfunction Drugs for Elderly Females$692,527
R01 · FY2023 · AG · contact PI
The Role of Erythroferrone in Regulating Bone Metabolism in Beta-Thalassemia$587,902
R01 · FY2023 · DK
Proof-of-Concept and Mechanistic Studies to Repurpose Erectile Dysfunction Drugs for Elderly Females$422,499
R01 · FY2023 · AG · contact PI
The Role of Erythroferrone in Regulating Bone Metabolism in Beta-Thalassemia$406,627
R01 · FY2023 · DK
A Humanized Monoclonal FSH Blocking Antibody for Alzheimer's Disease$1,657,121
U01 · FY2022 · AG
Elevated FSH - A Driver for Sex Differences in Alzheimer's Disease$1,267,500
R01 · FY2022 · AG
Proof-of-Concept and Mechanistic Studies to Repurpose Erectile Dysfunction Drugs for Elderly Females$692,527
R01 · FY2022 · AG · contact PI
The Role of Erythroferrone in Regulating Bone Metabolism in Beta-Thalassemia$598,312
R01 · FY2022 · DK
A Humanized Monoclonal FSH Blocking Antibody for Alzheimer's Disease$1,712,573
U01 · FY2021 · AG
Elevated FSH - A Driver for Sex Differences in Alzheimer's Disease$1,268,438
R01 · FY2021 · AG
Proof-of-Concept and Mechanistic Studies to Repurpose Erectile Dysfunction Drugs for Elderly Females$693,892
R01 · FY2021 · AG · contact PI